Author

Max Reinshagen

A RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PLACEBO-CONTROLLED, EUROPEAN MULTICENTRE TRIAL OF TWO NEW BUDESONIDE FORMULATIONS FOR TREATMENT OF ACTIVE EOSINOPHILIC ESOPHAGITIS

Petr Hruz, Stephan Miehlke, Ulrike von Arnim, Ahmed Madisch, Michael Vieth, Christiane Fibbe, Henning Wittenburg, Hans-Dieter Allescher, Max Reinshagen, Stefan Schubert, Jan Tack, Michaela Müller, Alexander J. Eckardt, Patrick Krummenerl, Joris Arts, Karin Dilger, Roland Greinwald, Alex Straumann

The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease

Marcus Harbord, Vito Annese, Stephan Vavricka, Matthieu Allez, Manuel Barreiro de Acosta, Kirsten Muri Boberg, Johan Burisch, Martine De Vos, Annemarie De Vries, Andrew Dick, Pascal Juillerat, Tom Hemming Karlsen, Ioannis Koutroubakis, Peter L Lakatos, Timothy Orchard, Pavol Papay, Tim Raine, Max Reinshagen, Diamant Thaci

Changing epidemiology of diverticulitis

Max Reinshagen

VEDOLIZUMAB FOR INFLAMMATORY BOWEL DISEASE IN CLINICAL PRACTICE – EXPERIENCE FROM A PROSPECTIVE GERMAN REGISTRY

Daniel C. Baumgart, Raja Atreya, Oliver Bachmann, Michael Bläker, Bernd Bokemeyer, Norbert Börner, Jürgen Büning, Axel Dignass, Atylla Drabik, Robert Ehehalt, Andreas Fischer, Franz Hartmann, Heinz Hartmann, Stefanie Howaldt, Petra Jessen, Thomas Krummenerl, Tanja Kuehbacher, Andreas Luegering, Jochen Maul, Michael Mross

Item 1 - 4 / 4
1